Lumacaftor (Qanatpharma)

N/A

Report date: 2023/11/10 17:47:19
NME

Base Information

Drug NameLumacaftor (Qanatpharma)
Drug Alias NameQP-01
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCystic fibrosis transmembrane conductance regulator modulators
TargetsCystic fibrosis transmembrane conductance regulator
Therapy Area/IndicationsHeart FailureSubarachnoid Hemorrhage
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesQanatpharma AG
China Registration ClassN/A

Develop Information

Active CompaniesQanatpharma AG
Inactive CompaniesN/A
Active IndicationsHeart FailureSubarachnoid Hemorrhage
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A